Before an innovative treatment can reach patients, one question is essential: is it safe?
In the latest Inside Medincell, Aurรฉlie, Preclinical Safety Leader, explains how preclinical safety helps turn long-acting innovation into new treatment options.
๐ Full episode in comments
๐จ๐ญ๐๐๐ฌยฎ ๐ฐ๐ผ๐ป๐๐ถ๐ป๐๐ฒ๐ ๐ถ๐๐ ๐๐๐ฟ๐ผ๐ป๐ด ๐ด๐ฟ๐ผ๐๐๐ต ๐๐ฟ๐ฎ๐ท๐ฒ๐ฐ๐๐ผ๐ฟ๐ ๐
๐น Q3 U.S. net sales: $85M, +96% YoY
๐น9M 2026: $225M, already above FY2025
For Medincell: growing royalties and further validation of BEPOยฎ at commercial scale.
#UZEDY
Heading to #OkinawaColloids2026 ๐ฏ๐ต
Pierre Berto, PhD, and Feifei Ng, PhD, will represent Medincell, with Pierre presenting new insights into how polymer-based in situ forming depots can be leveraged to tune drug release using BEPOยฎ technology.
#DrugDelivery#LongActingInjectables
Medincell is attending the 13th China Healthcare Summit in Shanghai (Nov 2-4). Meet Emma Guo to discuss partnership opportunities and how our BEPOยฎ technology enables long-acting therapeutic innovations. #ChinaHealthcareSummit#LongActingInjectables#BusinessDevelopment
See you at #PODD2026!
Looking to unlock the potential of long-acting injectables? Let's discuss how Medincell's BEPOยฎ technology can support your development strategy.
See you there.
https://t.co/6InFNdCsUL
#DrugDelivery#Biopharma
Heading to #PharmSci360? Meet the Medincell team in New Orleans!
Christophe Roberge & Adolfo Lopez Noriega look forward to connecting and discussing how Medincell's technology platform supports the development of differentiated therapeutic products.
๐ https://t.co/6InFNdBV5d
๐๏ธ Live webcast
Medincell's leadership team will host a press conference to discuss this historic achievement for the company and what comes next.
We look forward to sharing this special moment with you!
๐ Connection link in comments
#WELTRUZA
๐ข Breaking news: WELTRUZAโข has received U.S. FDA approval for the treatment of adults living with schizophrenia.
As the first and only subcutaneous long-acting olanzapine, WELTRUZAโข represents a significant advancement in schizophrenia care.
๐ Link to PR in comments
Heading to #Sachs_BEF? Meet Medincell in Basel on Oct 7-8 to discuss strategic partnerships, licensing opportunities, and the potential of our BEPOยฎ technology platform. #DrugDelivery#LAI
Ever wonder what a day in the life of a Process Development Engineer looks like ๐?
Step into the day of Laura Manzoli, Process Development Engineer at Medincell.
๐ Check out our open positions: https://t.co/zzyktm1IZh
#Pharmacareers
Just recorded with Christophe Douat, the CEO of @MedinCell $MEDCL, in Montpellier ๐๏ธโ๏ธ๐ซ๐ท great story, both personal and the biotech. Out next week!
Skills get you noticed. Mindset helps you thrive.
๐๏ธ Cรฉdric Bouaraba shares what makes a great fit at Medincell.
๐ Watch full video: https://t.co/XKdlNW7zQO
#Biotech#Careers
Heading to Boston? Meet the Medincell team at #DDFSummit (Sept 14-15) and the Neuropsychiatric Drug Development Summit (Sept 16-17).
Let's discuss long-acting injectables and innovative drug delivery solutions.
๐ฃ #Medincell shareholders: join us on September 22 at 6:00 PM (Paris time) for a meeting ahead of the Annual General Meeting on September 30.
โ ๏ธ Please note that the meeting will be conducted exclusively in French.
๐ Information & registration: https://t.co/l3ua3Ng1l8
๐ฃ Actionnaires #Medincell : rendez-vous le 22 septembre ร 18h pour une rรฉunion prรฉparatoire ร lโAssemblรฉe gรฉnรฉrale du 30 septembre.
๐ Infos & inscription : https://t.co/l3ua3Ng1l8
#AG2026#Actionnaires#Gouvernance#Biotech
As companies grow, what should never change?
Culture. Ownership. Agility.
Discover our CPO Franck Pouzache's perspective in the latest episode of #InsideMedincell.
๐ฅ Link to full Episode in comment ๐